Accès ouvert
2019
dataset
OpenAlex
Ennio Zangrando, Enzo Alessio, G. Mestroni
An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, …
Accès ouvert
2019
dataset
OpenAlex
Ennio Zangrando, Enzo Alessio, G. Mestroni
An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, …
Accès ouvert
2019
dataset
OpenAlex
Ennio Zangrando, Enzo Alessio, G. Mestroni
An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, …
2014
article
OpenAlex
Vojtěch Novohradský, Alberta Bergamo, Moreno Cocchietto, Juraj Zajac et autres
NAMI-A is a ruthenium-based drug endowed with the unique property of selectively targeting solid tumour metastases. Although two clinical studies had already been completed, limited information exists on the behavior of NAMI-A after injection into the bloodstream. PK data in humans informs …
cz, us, it
(code pays fourni par la source)
Accès ouvert
2006
dataset
OpenAlex
Alessandro Scarel, J. Durand, Daniele Franchi, Ennio Zangrando et autres
An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, …
Accès ouvert
2006
dataset
OpenAlex
Alessandro Scarel, J. Durand, Daniele Franchi, Ennio Zangrando et autres
An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, …
2005
article
OpenAlex
Alessandro Scarel, Jérôme Durand, Davide Franchi, Ennio Zangrando et autres
The coordination chemistry of the chiral bioxazoline ligand (4S,4'S)-2,2'-bis(4-isopropyl-4,5-dihydrooxazole) to Pd(II) provides evidence that the ligand bonding can occur either through chelation of one Pd(II) ion leading to a mononuclear species with the expected cis geometry, or by double bridging of two …
it, ch
(code pays fourni par la source)
2005
article
OpenAlex
Alessandro Scarel, Jérôme Durand, Davide Franchi, Ennio Zangrando et autres
it
(code pays fourni par la source)
2005
article
OpenAlex
Alessandro Scarel, Jérôme Durand, Bárbara Milani, Ennio Zangrando et autres
Accès ouvert
2005
dataset
OpenAlex
Alessandro Scarel, J. Durand, Daniele Franchi, Ennio Zangrando et autres
An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, …
Accès ouvert
2005
dataset
OpenAlex
Alessandro Scarel, J. Durand, Daniele Franchi, Ennio Zangrando et autres
An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, …
2004
article
OpenAlex
Enzo Alessio, G. Mestroni, Alberta Bergamo, Gianni Sava
NAMI-A, i. e. (imH)[trans-RuCl(4)(dmso-S)(im)] (im = imidazole, dmso = dimethylsulfoxide), is a Ru(III) complex that, after extensive preclinical investigations that evidenced its remarkable and specific activity against metastases, has recently and successfully completed a Phase I trial (first ruthenium complex ever to …
it
(code pays fourni par la source)